{
  "id": "map_1854",
  "title": "E.Graves\\N[TRAb]",
  "specialty": "Endocrinología",
  "tag": "⭐ Estudio Pivotal",
  "node_count": 742,
  "root": {
    "text": "E.Graves\\N[TRAb]",
    "children": [
      {
        "text": "→ Definición",
        "children": [
          {
            "text": "└─ Trastorno AI multisistémico + TRAb",
            "children": []
          }
        ]
      },
      {
        "text": "→ Epidemiología",
        "children": [
          {
            "text": "├─ Todos casos: 350/millón/año",
            "children": []
          },
          {
            "text": "├─ HiperT Graves: 325/millón/año",
            "children": []
          },
          {
            "text": "└─ ♀:♂ = 4:1",
            "children": []
          }
        ]
      },
      {
        "text": "FENOTIPOS\\N{% afectados}",
        "children": [
          {
            "text": "→ HiperT Graves {90-95%}",
            "children": []
          },
          {
            "text": "→ Bocio {50%}",
            "children": []
          },
          {
            "text": "→ Orbitopatía",
            "children": [
              {
                "text": "├─ Total {30%}",
                "children": []
              },
              {
                "text": "└─ Grave {5%}",
                "children": []
              }
            ]
          },
          {
            "text": "→ Dermopatía {0.5%}",
            "children": []
          },
          {
            "text": "→ HiperT neonatal {0. 2%}",
            "children": []
          },
          {
            "text": "→ Acropaquía {0.1%}",
            "children": []
          }
        ]
      },
      {
        "text": "PRESENTACIÓN\\NCLÍNICA",
        "children": [
          {
            "text": "→ Edad media: 47a",
            "children": []
          },
          {
            "text": "→ Síntomas típicos",
            "children": [
              {
                "text": "├─ ↓Peso",
                "children": []
              },
              {
                "text": "├─ ↑Apetito",
                "children": []
              },
              {
                "text": "├─ Intolerancia calor",
                "children": []
              },
              {
                "text": "├─ Sudoración",
                "children": []
              },
              {
                "text": "├─ Palpitaciones",
                "children": []
              },
              {
                "text": "└─ Temblor fino",
                "children": []
              }
            ]
          },
          {
            "text": "→ Duración media síntomas",
            "children": [
              {
                "text": "└─ 6 meses {61% pacientes}",
                "children": []
              }
            ]
          }
        ]
      },
      {
        "text": "FACTORES\\NRIESGO",
        "children": [
          {
            "text": "→ AF tiroideos AI {50%}",
            "children": []
          },
          {
            "text": "→ Predisposición genética",
            "children": []
          },
          {
            "text": "→ Edad >30a → estable",
            "children": []
          },
          {
            "text": "→ Tabaquismo",
            "children": []
          }
        ]
      },
      {
        "text": "ANATOMÍA\\NPATOLÓGICA",
        "children": [
          {
            "text": "→ Tiroides",
            "children": [
              {
                "text": "├─ Hipertrófica difusa",
                "children": []
              },
              {
                "text": "├─ Epitelio cilíndrico hiperplásico",
                "children": []
              },
              {
                "text": "├─ ↓Coloide",
                "children": []
              },
              {
                "text": "└─ Vacuolización",
                "children": []
              }
            ]
          },
          {
            "text": "→ Infiltrado",
            "children": [
              {
                "text": "└─ Linfocitos + células plasmáticas",
                "children": []
              }
            ]
          }
        ]
      },
      {
        "text": "INMUNOPATOGENIA\\NGRAVES",
        "children": [
          {
            "text": "CARACTERÍSTICAS\\NGENERALES",
            "children": [
              {
                "text": "→ Enfermedad\\NAI compleja",
                "children": [
                  {
                    "text": "├─ Multifactorial",
                    "children": []
                  },
                  {
                    "text": "├─ Base genética",
                    "children": []
                  },
                  {
                    "text": "└─ Influencia ambiental",
                    "children": []
                  }
                ]
              }
            ]
          },
          {
            "text": "MECANISMOS\\NBÁSICOS",
            "children": [
              {
                "text": "→ Pérdida\\Ntolerancia",
                "children": [
                  {
                    "text": "├─ Antígenos tiroideos propios",
                    "children": []
                  },
                  {
                    "text": "└─ Células T inmaduras → timo",
                    "children": []
                  }
                ]
              },
              {
                "text": "→ Células T\\Nautorreactivas",
                "children": [
                  {
                    "text": "├─ Alta afinidad → apoptosis",
                    "children": []
                  },
                  {
                    "text": "└─ Afinidad moderada → maduración",
                    "children": []
                  }
                ]
              }
            ]
          },
          {
            "text": "REGULACIÓN\\NINMUNE",
            "children": [
              {
                "text": "→ Células\\NT reg",
                "children": [
                  {
                    "text": "├─ CD4+/CD25+",
                    "children": []
                  },
                  {
                    "text": "├─ FOXP3+",
                    "children": []
                  },
                  {
                    "text": "└─ Producen IL-10/TGF-β",
                    "children": []
                  }
                ]
              },
              {
                "text": "→ Células\\NTh17",
                "children": [
                  {
                    "text": "├─ Proinflamatorias",
                    "children": []
                  },
                  {
                    "text": "└─ IL-17 → ↑respuesta inmune",
                    "children": []
                  }
                ]
              },
              {
                "text": "→ Balance\\NTh17/Treg",
                "children": [
                  {
                    "text": "└─ Crucial homeostasis",
                    "children": []
                  }
                ]
              }
            ]
          },
          {
            "text": "HISTOPATOLOGÍA",
            "children": [
              {
                "text": "→ Infiltrado\\Nlinfocitario",
                "children": [
                  {
                    "text": "├─ Células B",
                    "children": []
                  },
                  {
                    "text": "├─ Células T CD4+",
                    "children": []
                  },
                  {
                    "text": "└─ Th1/Th2",
                    "children": []
                  }
                ]
              },
              {
                "text": "→ Expresión HLA clase II",
                "children": []
              },
              {
                "text": "→ Cambios\\Npost-tratamiento",
                "children": [
                  {
                    "text": "├─ ↓Hiperplasia",
                    "children": []
                  },
                  {
                    "text": "├─ ↓Vascularización",
                    "children": []
                  },
                  {
                    "text": "└─ ↑Coloide folicular",
                    "children": []
                  }
                ]
              }
            ]
          }
        ]
      },
      {
        "text": "RECEPTOR\\NTSH (rTSH)",
        "children": [
          {
            "text": "→ Estructura",
            "children": [
              {
                "text": "├─ Familia receptores acoplados proteína G",
                "children": []
              },
              {
                "text": "├─ 7 dominios transmembrana",
                "children": []
              },
              {
                "text": "├─ Dominio extracelular grande",
                "children": []
              },
              {
                "text": "└─ Dominio intracelular pequeño",
                "children": []
              }
            ]
          },
          {
            "text": "→ Componentes",
            "children": [
              {
                "text": "├─ BEC: bucles extracelulares",
                "children": []
              },
              {
                "text": "├─ BIC: bucles intracelulares",
                "children": []
              },
              {
                "text": "├─ DTM: dominio transmembrana",
                "children": []
              },
              {
                "text": "├─ Subunidad α {50kDa}",
                "children": [
                  {
                    "text": "└─ Hidrosoluble + glucosilada",
                    "children": []
                  }
                ]
              },
              {
                "text": "└─ Subunidad β {30kDa}",
                "children": [
                  {
                    "text": "└─ No hidrosoluble",
                    "children": []
                  }
                ]
              }
            ]
          }
        ]
      },
      {
        "text": "ETIOLOGÍA",
        "children": [
          {
            "text": "→ Factores\\Nexistenciales",
            "children": [
              {
                "text": "├─ ♀ > ♂ {7.2:1}",
                "children": []
              },
              {
                "text": "├─ Edad típica: 30-50a",
                "children": []
              },
              {
                "text": "└─ ↑Riesgo postparto",
                "children": []
              }
            ]
          },
          {
            "text": "→ Mecanismos",
            "children": [
              {
                "text": "├─ TRAb estimulantes",
                "children": []
              },
              {
                "text": "├─ IgG1 predominante",
                "children": []
              },
              {
                "text": "└─ Activan vías AMPc",
                "children": [
                  {
                    "text": "├─ Citocinas Th1/Th2",
                    "children": []
                  },
                  {
                    "text": "├─ IL-4 → IgG4",
                    "children": []
                  },
                  {
                    "text": "└─ IFN-γ → IgG1",
                    "children": []
                  }
                ]
              },
              {
                "text": "└─ Células B → plasmáticas",
                "children": []
              }
            ]
          },
          {
            "text": "→ Evidencia\\Nexperimental",
            "children": [
              {
                "text": "├─ Modelo animal → ratones SCID",
                "children": []
              },
              {
                "text": "├─ Trasplante tejido tiroideo",
                "children": []
              },
              {
                "text": "└─ TRAb persisten post-tiroidectomía",
                "children": []
              }
            ]
          }
        ]
      },
      {
        "text": "FACTORES\\NETIOPATOGÉNICOS\\NGRAVES",
        "children": [
          {
            "text": "ENTORNO",
            "children": [
              {
                "text": "→ Factores ambientales",
                "children": [
                  {
                    "text": "├─ Yodo",
                    "children": []
                  },
                  {
                    "text": "├─ Tabaquismo",
                    "children": []
                  },
                  {
                    "text": "├─ Alcohol",
                    "children": []
                  },
                  {
                    "text": "├─ Selenio",
                    "children": []
                  },
                  {
                    "text": "├─ Estrés",
                    "children": []
                  },
                  {
                    "text": "├─ Infecciones",
                    "children": []
                  },
                  {
                    "text": "└─ Fármacos",
                    "children": []
                  }
                ]
              }
            ]
          },
          {
            "text": "GENES",
            "children": [
              {
                "text": "→ Principales",
                "children": [
                  {
                    "text": "├─ TSHR",
                    "children": []
                  },
                  {
                    "text": "├─ Tg",
                    "children": []
                  },
                  {
                    "text": "├─ HLA",
                    "children": []
                  },
                  {
                    "text": "├─ IL2A",
                    "children": []
                  },
                  {
                    "text": "├─ CD25",
                    "children": []
                  },
                  {
                    "text": "├─ CD40",
                    "children": []
                  },
                  {
                    "text": "├─ CTLA4",
                    "children": []
                  },
                  {
                    "text": "└─ PTPN22",
                    "children": []
                  }
                ]
              }
            ]
          },
          {
            "text": "FACTORES\\NEXISTENCIALES",
            "children": [
              {
                "text": "→ Características",
                "children": [
                  {
                    "text": "├─ Sexo femenino",
                    "children": []
                  },
                  {
                    "text": "└─ Embarazos a término",
                    "children": []
                  }
                ]
              }
            ]
          },
          {
            "text": "INTERACCIONES\\NENTORNO",
            "children": [
              {
                "text": "→ Yodo",
                "children": [
                  {
                    "text": "├─ AI tiroidea → TgAb",
                    "children": [
                      {
                        "text": "└─ Suplementación",
                        "children": []
                      }
                    ]
                  },
                  {
                    "text": "├─ Corto plazo → ↑BMN/adenoma",
                    "children": []
                  },
                  {
                    "text": "└─ Largo plazo → ↓incidencia",
                    "children": []
                  }
                ]
              },
              {
                "text": "→ Tabaquismo",
                "children": [
                  {
                    "text": "├─ OR: 3.3 {IC:2.09-5.22}",
                    "children": []
                  },
                  {
                    "text": "└─ Riesgo ↓ post-abandono",
                    "children": []
                  }
                ]
              },
              {
                "text": "→ Alcohol",
                "children": [
                  {
                    "text": "├─ Consumo moderado → ↓riesgo",
                    "children": [
                      {
                        "text": "└─ Cocientes probabilidad",
                        "children": []
                      }
                    ]
                  },
                  {
                    "text": "├─ 1-2u/sem: 0.56",
                    "children": []
                  },
                  {
                    "text": "├─ 3-10u/sem: 0.37",
                    "children": []
                  },
                  {
                    "text": "└─ >21u/sem: 0.22",
                    "children": []
                  }
                ]
              },
              {
                "text": "→ Selenio",
                "children": [
                  {
                    "text": "└─ Déficit → ↑riesgo HiperT AI",
                    "children": []
                  }
                ]
              },
              {
                "text": "→ Estrés",
                "children": [
                  {
                    "text": "└─ Factor desencadenante histórico",
                    "children": []
                  }
                ]
              }
            ]
          },
          {
            "text": "INFECCIONES",
            "children": [
              {
                "text": "→ Mimetismo\\Nmolecular",
                "children": [
                  {
                    "text": "├─ Y. enterocolitica → ↓unión TSH",
                    "children": []
                  },
                  {
                    "text": "├─ Proteínas VE",
                    "children": []
                  },
                  {
                    "text": "└─ Reactividad cruzada",
                    "children": []
                  }
                ]
              },
              {
                "text": "→ Lesión\\Nlocal",
                "children": [
                  {
                    "text": "├─ Trauma/infección → infiltrado",
                    "children": []
                  },
                  {
                    "text": "├─ ↑HLA clase II",
                    "children": []
                  },
                  {
                    "text": "└─ Activación células T autorreactivas",
                    "children": []
                  }
                ]
              }
            ]
          },
          {
            "text": "FÁRMACOS",
            "children": [
              {
                "text": "→ Interferón α",
                "children": [
                  {
                    "text": "├─ Efectos citotóxicos directos",
                    "children": []
                  },
                  {
                    "text": "└─ Respuestas AI destructivas",
                    "children": []
                  }
                ]
              },
              {
                "text": "→ Inmunoterapia",
                "children": [
                  {
                    "text": "├─ Alemtuzumab {anti-CD52}",
                    "children": []
                  },
                  {
                    "text": "├─ Nivolumab {anti-PD1}",
                    "children": []
                  },
                  {
                    "text": "└─ Ipilimumab {anti-CTLA4}",
                    "children": []
                  }
                ]
              }
            ]
          }
        ]
      },
      {
        "text": "ANTICUERPOS\\NrTSH (TRAb)",
        "children": [
          {
            "text": "→ Tipos",
            "children": [
              {
                "text": "├─ TBII: inmunoglobulinas inhibidoras",
                "children": []
              },
              {
                "text": "├─ TSAb: Ac estimulantes",
                "children": []
              },
              {
                "text": "└─ TBAb: Ac bloqueantes",
                "children": []
              }
            ]
          },
          {
            "text": "→ Indicaciones\\Ndeterminación",
            "children": [
              {
                "text": "├─ Diagnóstico",
                "children": []
              },
              {
                "text": "├─ HiperT Graves",
                "children": []
              },
              {
                "text": "├─ Orbitopatía/dermopatía",
                "children": [
                  {
                    "text": "└─ Tirotoxicosis fetal/neonatal",
                    "children": []
                  }
                ]
              },
              {
                "text": "└─ Tratamiento",
                "children": [
                  {
                    "text": "└─ Probabilidad remisión",
                    "children": []
                  }
                ]
              }
            ]
          }
        ]
      },
      {
        "text": "DIAGNÓSTICO (2,3)",
        "children": [
          {
            "text": "→ Laboratorio",
            "children": [
              {
                "text": "├─ TSH ↓",
                "children": []
              },
              {
                "text": "├─ T4L/T3L ↑",
                "children": []
              },
              {
                "text": "└─ TRAb {S:97%, E:98%}",
                "children": []
              }
            ]
          },
          {
            "text": "→ Imagen",
            "children": [
              {
                "text": "├─ ECO tiroides + Doppler",
                "children": []
              },
              {
                "text": "└─ Gammagrafía {selectiva}",
                "children": []
              }
            ]
          }
        ]
      },
      {
        "text": "TRATAMIENTO CON\\NANTITIROIDEOS GRAVES",
        "children": [
          {
            "text": "FÁRMACOS",
            "children": [
              {
                "text": "→ Tionamidas",
                "children": [
                  {
                    "text": "├─ Metimazol (MMI)",
                    "children": []
                  },
                  {
                    "text": "├─ 1ª elección",
                    "children": [
                      {
                        "text": "└─ 5-30mg/d",
                        "children": []
                      }
                    ]
                  },
                  {
                    "text": "└─ Propiltiouracilo (PTU)",
                    "children": [
                      {
                        "text": "├─ Embarazo 1°trim",
                        "children": []
                      },
                      {
                        "text": "└─ 300-400mg/d dividido",
                        "children": []
                      }
                    ]
                  }
                ]
              }
            ]
          },
          {
            "text": "MONITORIZACIÓN",
            "children": [
              {
                "text": "→ Pre-tratamiento",
                "children": [
                  {
                    "text": "├─ Hemograma",
                    "children": []
                  },
                  {
                    "text": "├─ Perfil hepático",
                    "children": []
                  },
                  {
                    "text": "└─ Control leucocitos periódico",
                    "children": []
                  }
                ]
              },
              {
                "text": "→ Durante tratamiento",
                "children": [
                  {
                    "text": "├─ T4L/T3L → 6 sem",
                    "children": []
                  },
                  {
                    "text": "└─ Ajustes cada 4-8 sem",
                    "children": []
                  }
                ]
              }
            ]
          },
          {
            "text": "EFECTOS ADVERSOS\\NGRAVES",
            "children": [
              {
                "text": "→ MMI",
                "children": [
                  {
                    "text": "└─ Hepatitis {leve}",
                    "children": []
                  }
                ]
              },
              {
                "text": "→ PTU",
                "children": [
                  {
                    "text": "├─ Agranulocitosis {1-2%}",
                    "children": []
                  },
                  {
                    "text": "├─ Hepatitis fulminante",
                    "children": []
                  },
                  {
                    "text": "└─ Suspender inmediatamente",
                    "children": []
                  }
                ]
              }
            ]
          },
          {
            "text": "REMISIÓN",
            "children": [
              {
                "text": "→ Factores favorables",
                "children": [
                  {
                    "text": "├─ ↓Tamaño bocio",
                    "children": []
                  },
                  {
                    "text": "├─ ↓TRAb",
                    "children": []
                  },
                  {
                    "text": "└─ Normalización TSH",
                    "children": []
                  }
                ]
              },
              {
                "text": "→ Tasas",
                "children": [
                  {
                    "text": "├─ 12-18m → 40-60%",
                    "children": []
                  },
                  {
                    "text": "└─ Recaída → 48.7%",
                    "children": []
                  }
                ]
              }
            ]
          }
        ]
      },
      {
        "text": "SCORE GREAT/GREAT+\\NPREDICCIÓN RECIDIVA GRAVES",
        "children": [
          {
            "text": "SISTEMA GREAT\\N(0-6 puntos)",
            "children": [
              {
                "text": "→ Edad",
                "children": [
                  {
                    "text": "├─ ≥40a → 0",
                    "children": []
                  },
                  {
                    "text": "└─ <40a → +1",
                    "children": []
                  }
                ]
              },
              {
                "text": "→ T4L",
                "children": [
                  {
                    "text": "├─ <40 → 0",
                    "children": []
                  },
                  {
                    "text": "└─ ≥40 → +1",
                    "children": []
                  }
                ]
              },
              {
                "text": "→ TBII",
                "children": [
                  {
                    "text": "├─ <6 → 0",
                    "children": []
                  },
                  {
                    "text": "├─ 6-19.9 → +1",
                    "children": []
                  },
                  {
                    "text": "└─ ≥20 → +2",
                    "children": []
                  }
                ]
              },
              {
                "text": "→ Tamaño\\Nbocio",
                "children": [
                  {
                    "text": "├─ gr. 0-I → 0",
                    "children": []
                  },
                  {
                    "text": "└─ gr. II-III → +2",
                    "children": []
                  }
                ]
              }
            ]
          },
          {
            "text": "SISTEMA GREAT+\\N(0-10 puntos)",
            "children": [
              {
                "text": "→ PTPN22 C/C\\Nnatural",
                "children": [
                  {
                    "text": "├─ C/C → 0",
                    "children": []
                  },
                  {
                    "text": "└─ C/T → +1",
                    "children": []
                  }
                ]
              },
              {
                "text": "→ N° HLA",
                "children": [
                  {
                    "text": "├─ 0 → 0",
                    "children": []
                  },
                  {
                    "text": "├─ 1-2 → +2",
                    "children": []
                  },
                  {
                    "text": "└─ ≥3 → +3",
                    "children": []
                  }
                ]
              }
            ]
          },
          {
            "text": "RIESGO RECIDIVA\\NGREAT",
            "children": [
              {
                "text": "→ Clase I {0-1p}: 16%",
                "children": []
              },
              {
                "text": "→ Clase II {2-3p}: 44%",
                "children": []
              },
              {
                "text": "→ Clase III {4-6p}: 68%",
                "children": []
              }
            ]
          },
          {
            "text": "RIESGO RECIDIVA\\NGREAT+",
            "children": [
              {
                "text": "→ Clase I+ {0-2p}: 4%",
                "children": []
              },
              {
                "text": "→ Clase II+ {3-4p}: 21%",
                "children": []
              },
              {
                "text": "→ Clase III+ {5-6p}: 49%",
                "children": []
              },
              {
                "text": "→ Clase IV+ {7-10p}: 84%",
                "children": []
              }
            ]
          }
        ]
      },
      {
        "text": "β-BLOQUEANTES",
        "children": [
          {
            "text": "→ Indicaciones",
            "children": [
              {
                "text": "├─ Tirotoxicosis sintomática",
                "children": []
              },
              {
                "text": "└─ FC >90 o ECV",
                "children": []
              }
            ]
          },
          {
            "text": "→ Fármacos/dosis",
            "children": [
              {
                "text": "├─ Propranolol",
                "children": [
                  {
                    "text": "├─ 20mg/6h",
                    "children": []
                  },
                  {
                    "text": "└─ ↑160mg/d",
                    "children": []
                  }
                ]
              },
              {
                "text": "├─ Atenolol",
                "children": [
                  {
                    "text": "└─ 25-100mg/12-24h",
                    "children": []
                  }
                ]
              },
              {
                "text": "└─ Metoprolol",
                "children": [
                  {
                    "text": "└─ 25mg/8h",
                    "children": []
                  }
                ]
              }
            ]
          },
          {
            "text": "→ Efectos",
            "children": [
              {
                "text": "├─ ↓20% T3 plasmática",
                "children": []
              },
              {
                "text": "├─ ↓Temblor",
                "children": []
              },
              {
                "text": "└─ ↓Palpitaciones",
                "children": []
              }
            ]
          }
        ]
      },
      {
        "text": "YODO",
        "children": [
          {
            "text": "→ Formas",
            "children": [
              {
                "text": "├─ SSKI: solución saturada KI",
                "children": []
              },
              {
                "text": "└─ Lugol",
                "children": []
              }
            ]
          },
          {
            "text": "→ Dosis",
            "children": [
              {
                "text": "├─ SSKI: 2-3gts/12h",
                "children": []
              },
              {
                "text": "└─ Lugol: 4-8gts/8h",
                "children": []
              }
            ]
          },
          {
            "text": "→ Indicaciones",
            "children": [
              {
                "text": "├─ Pre-cirugía",
                "children": []
              },
              {
                "text": "└─ Crisis tiroidea",
                "children": []
              }
            ]
          },
          {
            "text": "→ Limitaciones",
            "children": [
              {
                "text": "└─ Escape efecto Wolff-Chaikoff",
                "children": []
              }
            ]
          }
        ]
      },
      {
        "text": "OTROS\\NFÁRMACOS",
        "children": [
          {
            "text": "→ Colestiramina",
            "children": [
              {
                "text": "├─ Interfiere ciclo enterohepático",
                "children": []
              },
              {
                "text": "└─ ↓HT rápida",
                "children": []
              }
            ]
          },
          {
            "text": "→ Selenio",
            "children": [
              {
                "text": "├─ ↓TRAb en remisión",
                "children": []
              },
              {
                "text": "└─ Dosis: 300μg/d",
                "children": []
              }
            ]
          },
          {
            "text": "→ Litio",
            "children": [
              {
                "text": "├─ ↓Secreción HT",
                "children": []
              },
              {
                "text": "└─ 300-450mg/8h",
                "children": []
              }
            ]
          },
          {
            "text": "→ Perclorato",
            "children": [
              {
                "text": "→ Mecanismo",
                "children": [
                  {
                    "text": "└─ Inhibe transporte yodo",
                    "children": []
                  }
                ]
              },
              {
                "text": "→ Uso limitado",
                "children": [
                  {
                    "text": "└─ Efectos adversos",
                    "children": []
                  }
                ]
              }
            ]
          },
          {
            "text": "→ Yodo y\\Ncombinaciones",
            "children": [
              {
                "text": "→ SSKI/Lugol",
                "children": [
                  {
                    "text": "├─ Dosis mínima: 6mg",
                    "children": []
                  },
                  {
                    "text": "├─ 2-3 gotas SSKI/12h {máximo}",
                    "children": []
                  },
                  {
                    "text": "└─ Mejor + MMI vs monoterapia",
                    "children": []
                  }
                ]
              },
              {
                "text": "→ Limitaciones",
                "children": [
                  {
                    "text": "├─ RAM: conjuntivitis",
                    "children": []
                  },
                  {
                    "text": "└─ Escape Wolff-Chaikoff",
                    "children": []
                  }
                ]
              }
            ]
          },
          {
            "text": "→ Inmunosupresores",
            "children": [
              {
                "text": "→ Resultados\\Nensayos",
                "children": [
                  {
                    "text": "├─ Recidivas: 24% vs 59%",
                    "children": []
                  },
                  {
                    "text": "├─ HR: 0.55 (IC:0.41-0.75)",
                    "children": []
                  },
                  {
                    "text": "└─ p<0.001",
                    "children": []
                  }
                ]
              },
              {
                "text": "→ Limitaciones\\Nestudios",
                "children": [
                  {
                    "text": "├─ Tamaño muestral pequeño",
                    "children": []
                  },
                  {
                    "text": "└─ Riesgo sesgo moderado",
                    "children": []
                  }
                ]
              }
            ]
          },
          {
            "text": "→ En desarrollo",
            "children": [
              {
                "text": "├─ Inmunoterapia específica",
                "children": []
              },
              {
                "text": "├─ Péptidos tolerógenos r-TSH",
                "children": []
              },
              {
                "text": "├─ Ac monoclonales bloqueantes",
                "children": []
              },
              {
                "text": "└─ Antagonistas receptores TSH bajo PM",
                "children": []
              }
            ]
          }
        ]
      },
      {
        "text": "TIROIDECTOMÍA",
        "children": [
          {
            "text": "→ Resultados",
            "children": [
              {
                "text": "├─ Total: 9% recidiva",
                "children": []
              },
              {
                "text": "└─ Subtotal: 58% recidiva 5a",
                "children": []
              }
            ]
          },
          {
            "text": "→ Complicaciones",
            "children": [
              {
                "text": "├─ Hipoparatiroidismo",
                "children": [
                  {
                    "text": "├─ Permanente <2%",
                    "children": []
                  },
                  {
                    "text": "└─ Transitorio: 1-7d",
                    "children": []
                  }
                ]
              },
              {
                "text": "└─ Lesión NLR",
                "children": [
                  {
                    "text": "├─ Permanente <1%",
                    "children": []
                  },
                  {
                    "text": "└─ Transitorio 0.3-0.7%",
                    "children": []
                  }
                ]
              }
            ]
          },
          {
            "text": "PREPARACIÓN\\NQUIRÚRGICA",
            "children": [
              {
                "text": "→ Pre-operatorio",
                "children": [
                  {
                    "text": "├─ Control hipertiroidismo",
                    "children": []
                  },
                  {
                    "text": "├─ β-bloqueantes",
                    "children": []
                  },
                  {
                    "text": "└─ KI/Lugol 7-10d",
                    "children": []
                  }
                ]
              },
              {
                "text": "→ Controles",
                "children": [
                  {
                    "text": "├─ Ca/25OH-vitD",
                    "children": []
                  },
                  {
                    "text": "└─ Función tiroidea",
                    "children": []
                  }
                ]
              },
              {
                "text": "→ Post-operatorio",
                "children": [
                  {
                    "text": "├─ Levotiroxina 1.6μg/kg/d",
                    "children": []
                  },
                  {
                    "text": "└─ TSH 6 semanas",
                    "children": []
                  }
                ]
              }
            ]
          }
        ]
      },
      {
        "text": "YODO RADIOACTIVO (RAI)\\NEN GRAVES",
        "children": [
          {
            "text": "CARACTERÍSTICAS\\NGENERALES",
            "children": [
              {
                "text": "→ Historia",
                "children": [
                  {
                    "text": "└─ Uso desde 1941",
                    "children": []
                  }
                ]
              },
              {
                "text": "→ Eficacia",
                "children": [
                  {
                    "text": "├─ 90% éxito inicial",
                    "children": []
                  },
                  {
                    "text": "└─ Normalización tamaño 1a {45-90%}",
                    "children": []
                  }
                ]
              },
              {
                "text": "→ Dosis habitual",
                "children": [
                  {
                    "text": "└─ 10-30mCi",
                    "children": []
                  }
                ]
              }
            ]
          },
          {
            "text": "CONSIDERACIONES\\NESPECIALES",
            "children": [
              {
                "text": "→ Riesgo cáncer",
                "children": [
                  {
                    "text": "├─ Adultos: mínimo",
                    "children": []
                  },
                  {
                    "text": "└─ Niños 5a {15mCi}: 4%",
                    "children": []
                  }
                ]
              },
              {
                "text": "→ Contraindicaciones\\Nabsolutas",
                "children": [
                  {
                    "text": "├─ Embarazo",
                    "children": []
                  },
                  {
                    "text": "└─ Lactancia",
                    "children": []
                  }
                ]
              },
              {
                "text": "→ Oftalmopatía",
                "children": [
                  {
                    "text": "└─ ↑15% casos post-RAI",
                    "children": []
                  }
                ]
              }
            ]
          },
          {
            "text": "EVOLUCIÓN\\NTRAb",
            "children": [
              {
                "text": "→ Comparación\\Ntratamientos",
                "children": [
                  {
                    "text": "├─ RAI: ↑persistente 5a",
                    "children": []
                  },
                  {
                    "text": "├─ Cirugía: ↓rápida",
                    "children": []
                  },
                  {
                    "text": "└─ Metimazol: ↓progresiva",
                    "children": []
                  }
                ]
              },
              {
                "text": "→ Implicaciones",
                "children": [
                  {
                    "text": "└─ RAI → ↑riesgo oftalmopatía",
                    "children": []
                  }
                ]
              }
            ]
          },
          {
            "text": "SEGUIMIENTO",
            "children": [
              {
                "text": "→ Control",
                "children": [
                  {
                    "text": "├─ T4L/TSH: 4-6 sem",
                    "children": []
                  },
                  {
                    "text": "└─ Duración: 6 meses",
                    "children": []
                  }
                ]
              },
              {
                "text": "→ Levotiroxina",
                "children": [
                  {
                    "text": "├─ Inicio: T4L límite bajo",
                    "children": []
                  },
                  {
                    "text": "└─ Dosis: según función residual",
                    "children": []
                  }
                ]
              }
            ]
          }
        ]
      },
      {
        "text": "ELECCIÓN\\NTRATAMIENTO GRAVES",
        "children": [
          {
            "text": "VENTAJAS/INCONVENIENTES",
            "children": [
              {
                "text": "→ Fármacos\\Nantitiroideos",
                "children": [
                  {
                    "text": "├─ Ventajas",
                    "children": [
                      {
                        "text": "└─ Remisión definitiva {35%}",
                        "children": []
                      }
                    ]
                  },
                  {
                    "text": "└─ Desventajas",
                    "children": [
                      {
                        "text": "├─ RAM",
                        "children": []
                      },
                      {
                        "text": "├─ Duración 12-18m",
                        "children": []
                      },
                      {
                        "text": "└─ Alta recidiva",
                        "children": []
                      }
                    ]
                  }
                ]
              },
              {
                "text": "→ Yodo\\Nradioactivo",
                "children": [
                  {
                    "text": "├─ Ventajas",
                    "children": [
                      {
                        "text": "├─ Simplicidad",
                        "children": []
                      },
                      {
                        "text": "└─ Baja recidiva",
                        "children": []
                      }
                    ]
                  },
                  {
                    "text": "└─ Desventajas",
                    "children": [
                      {
                        "text": "├─ Oftalmopatía",
                        "children": []
                      },
                      {
                        "text": "├─ LT4 vida",
                        "children": []
                      },
                      {
                        "text": "└─ ↑Riesgo Ca",
                        "children": []
                      }
                    ]
                  }
                ]
              },
              {
                "text": "→ Tiroidectomía",
                "children": [
                  {
                    "text": "├─ Ventajas",
                    "children": [
                      {
                        "text": "├─ Rapidez",
                        "children": []
                      },
                      {
                        "text": "└─ No recidivas",
                        "children": []
                      }
                    ]
                  },
                  {
                    "text": "└─ Desventajas",
                    "children": [
                      {
                        "text": "├─ Morbilidad",
                        "children": []
                      },
                      {
                        "text": "└─ LT4 vida",
                        "children": []
                      }
                    ]
                  }
                ]
              }
            ]
          },
          {
            "text": "INDICACIONES\\NESPECÍFICAS",
            "children": [
              {
                "text": "→ FAT\\Npreferente",
                "children": [
                  {
                    "text": "├─ Alta probabilidad remisión",
                    "children": []
                  },
                  {
                    "text": "├─ Oftalmopatía activa",
                    "children": []
                  },
                  {
                    "text": "├─ Comorbilidades",
                    "children": []
                  },
                  {
                    "text": "└─ Alto riesgo Qx",
                    "children": []
                  }
                ]
              },
              {
                "text": "→ RAI\\Npreferente",
                "children": [
                  {
                    "text": "├─ Hepatopatía",
                    "children": []
                  },
                  {
                    "text": "├─ RAM FAT graves",
                    "children": []
                  },
                  {
                    "text": "├─ Parálisis periódica",
                    "children": []
                  },
                  {
                    "text": "└─ IC/HTP",
                    "children": []
                  }
                ]
              },
              {
                "text": "→ Cirugía\\Npreferente",
                "children": [
                  {
                    "text": "├─ Sospecha cáncer",
                    "children": []
                  },
                  {
                    "text": "├─ Nódulos voluminosos",
                    "children": []
                  },
                  {
                    "text": "└─ Hiperparatiroidismo",
                    "children": []
                  }
                ]
              }
            ]
          }
        ]
      },
      {
        "text": "OFTALMOPATÍA\\NGRAVES (OG)",
        "children": [
          {
            "text": "PRESENTACIÓN\\NCLÍNICA",
            "children": [
              {
                "text": "→ Síntomas\\Niniciales",
                "children": [
                  {
                    "text": "├─ Cambio aspecto facial",
                    "children": []
                  },
                  {
                    "text": "├─ Enrojecimiento párpados",
                    "children": []
                  },
                  {
                    "text": "├─ Hinchazón periorbital",
                    "children": []
                  },
                  {
                    "text": "└─ Sensación arenilla",
                    "children": []
                  }
                ]
              },
              {
                "text": "→ Evolución",
                "children": [
                  {
                    "text": "├─ Retracción palpebral",
                    "children": []
                  },
                  {
                    "text": "├─ Exoftalmos {60%}",
                    "children": []
                  },
                  {
                    "text": "├─ Lagoftalmos",
                    "children": []
                  },
                  {
                    "text": "└─ Diplopía {50%}",
                    "children": []
                  }
                ]
              },
              {
                "text": "→ Complicaciones\\Ngraves",
                "children": [
                  {
                    "text": "├─ NOD {5%}",
                    "children": [
                      {
                        "text": "├─ ↓Agudeza visual",
                        "children": []
                      },
                      {
                        "text": "├─ Defectos campo",
                        "children": []
                      },
                      {
                        "text": "└─ ↓Visión color",
                        "children": []
                      }
                    ]
                  },
                  {
                    "text": "└─ Úlcera corneal {raro}",
                    "children": []
                  }
                ]
              }
            ]
          },
          {
            "text": "EPIDEMIOLOGÍA",
            "children": [
              {
                "text": "→ Incidencia",
                "children": [
                  {
                    "text": "├─ General: 42/millón/año",
                    "children": []
                  },
                  {
                    "text": "└─ OG moderada-grave: 5%",
                    "children": []
                  }
                ]
              },
              {
                "text": "→ Prevalencia\\NHiperT Graves",
                "children": [
                  {
                    "text": "├─ Total OG: 25-35%",
                    "children": []
                  },
                  {
                    "text": "├─ Leve: 10%",
                    "children": []
                  },
                  {
                    "text": "└─ Moderada-grave: 3%",
                    "children": []
                  }
                ]
              },
              {
                "text": "→ Temporalidad",
                "children": [
                  {
                    "text": "├─ 58% → remisión espontánea",
                    "children": []
                  },
                  {
                    "text": "├─ 75% → durante HiperT",
                    "children": []
                  },
                  {
                    "text": "└─ 25% → post-diagnóstico",
                    "children": []
                  }
                ]
              }
            ]
          },
          {
            "text": "PREVALENCIA\\NINICIAL",
            "children": [
              {
                "text": "→ Distribución\\Ngeneral",
                "children": [
                  {
                    "text": "├─ Ausente: 74%",
                    "children": []
                  },
                  {
                    "text": "├─ Leve: 20%",
                    "children": []
                  },
                  {
                    "text": "├─ Moderada-grave: 5.8%",
                    "children": []
                  },
                  {
                    "text": "└─ Riesgo ceguera: 0.3%",
                    "children": []
                  }
                ]
              }
            ]
          },
          {
            "text": "EVOLUCIÓN\\N18 MESES",
            "children": [
              {
                "text": "→ Sin OG inicial\\N(n=194)",
                "children": [
                  {
                    "text": "├─ Ausente: 87%",
                    "children": []
                  },
                  {
                    "text": "├─ Leve: 10%",
                    "children": []
                  },
                  {
                    "text": "└─ Moderada-grave: 3%",
                    "children": []
                  }
                ]
              },
              {
                "text": "→ OG inicial leve\\N(n=43)",
                "children": [
                  {
                    "text": "├─ Ausente: 58%",
                    "children": []
                  },
                  {
                    "text": "├─ Leve: 40%",
                    "children": []
                  },
                  {
                    "text": "└─ Moderada-grave: 2%",
                    "children": []
                  }
                ]
              }
            ]
          },
          {
            "text": "ANATOMÍA\\NPATOLÓGICA",
            "children": [
              {
                "text": "→ Características",
                "children": [
                  {
                    "text": "├─ ↑Músculos extraoculares",
                    "children": []
                  },
                  {
                    "text": "├─ ↑Tejido conectivo retroocular",
                    "children": []
                  },
                  {
                    "text": "└─ ↑GAGs (hialuronato)",
                    "children": []
                  }
                ]
              },
              {
                "text": "→ Consecuencias",
                "children": [
                  {
                    "text": "├─ Edema",
                    "children": []
                  },
                  {
                    "text": "├─ ↑Presión retroocular",
                    "children": []
                  },
                  {
                    "text": "├─ Proptosis",
                    "children": []
                  },
                  {
                    "text": "└─ Fibrosis muscular tardía",
                    "children": []
                  }
                ]
              }
            ]
          },
          {
            "text": "INMUNOPATOGENIA",
            "children": [
              {
                "text": "→ Características",
                "children": [
                  {
                    "text": "├─ Infiltrado linfocítico orbital",
                    "children": []
                  },
                  {
                    "text": "├─ Edema",
                    "children": []
                  },
                  {
                    "text": "└─ Fibrosis",
                    "children": []
                  }
                ]
              },
              {
                "text": "→ Células implicadas",
                "children": [
                  {
                    "text": "├─ T colaboradoras",
                    "children": []
                  },
                  {
                    "text": "├─ Macrófagos",
                    "children": []
                  },
                  {
                    "text": "└─ Células B",
                    "children": []
                  }
                ]
              },
              {
                "text": "→ Fibroblastos\\Norbitarios (FO)",
                "children": [
                  {
                    "text": "├─ Expresan r-TSH",
                    "children": []
                  },
                  {
                    "text": "├─ ↑IL-16/RANTES",
                    "children": []
                  },
                  {
                    "text": "└─ ↑Síntesis GAGs",
                    "children": []
                  }
                ]
              }
            ]
          },
          {
            "text": "FACTORES\\NGENÉTICOS/AMBIENTALES",
            "children": [
              {
                "text": "→ HLA",
                "children": [
                  {
                    "text": "└─ Similar HiperT/OG",
                    "children": []
                  }
                ]
              },
              {
                "text": "→ Tabaquismo",
                "children": [
                  {
                    "text": "├─ Factor riesgo OG",
                    "children": []
                  },
                  {
                    "text": "└─ OR: 2.8-6.73",
                    "children": []
                  }
                ]
              },
              {
                "text": "→ Radiaciones",
                "children": [
                  {
                    "text": "└─ RAI → ↑riesgo OG",
                    "children": []
                  }
                ]
              },
              {
                "text": "→ Riesgo\\Nacumulado/década",
                "children": [
                  {
                    "text": "├─ 17% fumadores activos",
                    "children": []
                  },
                  {
                    "text": "├─ 10% exfumadores",
                    "children": []
                  },
                  {
                    "text": "└─ 7% nunca fumadores",
                    "children": []
                  }
                ]
              }
            ]
          },
          {
            "text": "MECANISMOS\\NMOLECULARES",
            "children": [
              {
                "text": "→ Receptores implicados",
                "children": [
                  {
                    "text": "├─ r-TSH",
                    "children": []
                  },
                  {
                    "text": "└─ IGF1R",
                    "children": []
                  }
                ]
              },
              {
                "text": "→ Señalización",
                "children": [
                  {
                    "text": "├─ Vía PI3K",
                    "children": []
                  },
                  {
                    "text": "└─ CD34/CD40",
                    "children": []
                  }
                ]
              }
            ]
          },
          {
            "text": "SEÑALIZACIÓN\\NRECEPTORES",
            "children": [
              {
                "text": "→ r-TSH fibroblasto\\Norbitario",
                "children": [
                  {
                    "text": "├─ Unión TRAb estimulante",
                    "children": []
                  },
                  {
                    "text": "├─ Activación vía Gαs",
                    "children": []
                  },
                  {
                    "text": "├─ ↑AMPc",
                    "children": []
                  },
                  {
                    "text": "└─ Activación PI3K/AKT/mTOR",
                    "children": []
                  }
                ]
              },
              {
                "text": "→ IGF-1R",
                "children": [
                  {
                    "text": "├─ Activación vía PI3K",
                    "children": []
                  },
                  {
                    "text": "├─ Cross-talk r-TSH",
                    "children": []
                  },
                  {
                    "text": "└─ Señalización IRS1/2",
                    "children": []
                  }
                ]
              }
            ]
          },
          {
            "text": "EFECTOS\\NFIBROBLASTOS",
            "children": [
              {
                "text": "→ Vía adipogénica",
                "children": [
                  {
                    "text": "├─ Diferenciación adipocitos",
                    "children": []
                  },
                  {
                    "text": "└─ ↑Tejido adiposo orbital",
                    "children": []
                  }
                ]
              },
              {
                "text": "→ Vía metabólica",
                "children": [
                  {
                    "text": "├─ ↑Síntesis ácido hialurónico",
                    "children": []
                  },
                  {
                    "text": "└─ ↑GAGs",
                    "children": []
                  }
                ]
              }
            ]
          },
          {
            "text": "CONSECUENCIAS\\NFINALES",
            "children": [
              {
                "text": "→ Expansión tejidos",
                "children": [
                  {
                    "text": "├─ Músculos extraoculares",
                    "children": []
                  },
                  {
                    "text": "├─ Grasa orbital",
                    "children": []
                  },
                  {
                    "text": "└─ Tejido conectivo",
                    "children": []
                  }
                ]
              },
              {
                "text": "→ Manifestaciones",
                "children": [
                  {
                    "text": "├─ Proptosis",
                    "children": []
                  },
                  {
                    "text": "├─ Restricción movimiento",
                    "children": []
                  },
                  {
                    "text": "└─ Compresión nervio óptico",
                    "children": []
                  }
                ]
              }
            ]
          },
          {
            "text": "EVALUACIÓN\\NCLÍNICA OG",
            "children": [
              {
                "text": "INDICADORES GRAVEDAD\\N(NO SPECS)",
                "children": [
                  {
                    "text": "→ Clase 0: Sin signos/síntomas",
                    "children": []
                  },
                  {
                    "text": "→ Clase 1: Solo signos",
                    "children": [
                      {
                        "text": "└─ Apertura palpebral {mm}",
                        "children": []
                      }
                    ]
                  },
                  {
                    "text": "→ Clase 2: Tejidos blandos",
                    "children": [
                      {
                        "text": "└─ Hinchazón/enrojecimiento",
                        "children": []
                      }
                    ]
                  },
                  {
                    "text": "→ Clase 3: Proptosis",
                    "children": [
                      {
                        "text": "└─ Exoftalmómetro Hertel",
                        "children": []
                      }
                    ]
                  },
                  {
                    "text": "→ Clase 4: Músculos\\Nextraoculares",
                    "children": [
                      {
                        "text": "├─ Diplopía",
                        "children": []
                      },
                      {
                        "text": "└─ Alt. elevación",
                        "children": []
                      }
                    ]
                  },
                  {
                    "text": "→ Clase 5: Corneal",
                    "children": [
                      {
                        "text": "└─ Queratitis/úlceras",
                        "children": []
                      }
                    ]
                  },
                  {
                    "text": "→ Clase 6: NOD",
                    "children": [
                      {
                        "text": "└─ Evaluación visual completa",
                        "children": []
                      }
                    ]
                  }
                ]
              },
              {
                "text": "INDICADORES ACTIVIDAD\\N(PAC)",
                "children": [
                  {
                    "text": "→ Dolor\\N{1-2p}",
                    "children": [
                      {
                        "text": "├─ Retroocular espontáneo",
                        "children": []
                      },
                      {
                        "text": "└─ Al movimiento",
                        "children": []
                      }
                    ]
                  },
                  {
                    "text": "→ Inflamación\\N{1-3p}",
                    "children": [
                      {
                        "text": "├─ Párpados/conjuntiva",
                        "children": []
                      },
                      {
                        "text": "├─ Carúncula/pliegue",
                        "children": []
                      },
                      {
                        "text": "└─ Quemosis",
                        "children": []
                      }
                    ]
                  },
                  {
                    "text": "→ Alt. funcional\\N{1-3p}",
                    "children": [
                      {
                        "text": "├─ ↑Proptosis ≥2mm/3m",
                        "children": []
                      },
                      {
                        "text": "├─ ↓8° movilidad/3m",
                        "children": []
                      },
                      {
                        "text": "└─ ↓Agudeza visual/3m",
                        "children": []
                      }
                    ]
                  },
                  {
                    "text": "→ Puntuación\\Nmáxima",
                    "children": [
                      {
                        "text": "├─ Instantánea: 7",
                        "children": []
                      },
                      {
                        "text": "└─ Acumulada: 10",
                        "children": []
                      }
                    ]
                  }
                ]
              }
            ]
          },
          {
            "text": "TRATAMIENTO\\NOG",
            "children": [
              {
                "text": "MEDIDAS\\NGENERALES",
                "children": [
                  {
                    "text": "→ Manejo",
                    "children": [
                      {
                        "text": "├─ Centro especializado",
                        "children": []
                      },
                      {
                        "text": "├─ Equipo multidisciplinario",
                        "children": []
                      },
                      {
                        "text": "└─ Evaluación QoL",
                        "children": []
                      }
                    ]
                  },
                  {
                    "text": "→ Hábitos",
                    "children": [
                      {
                        "text": "├─ Abandono tabaco",
                        "children": []
                      },
                      {
                        "text": "└─ Medidas locales",
                        "children": []
                      }
                    ]
                  },
                  {
                    "text": "→ Soporte",
                    "children": [
                      {
                        "text": "├─ Lágrimas artificiales",
                        "children": []
                      },
                      {
                        "text": "├─ Sal fotofobia",
                        "children": []
                      },
                      {
                        "text": "├─ Lubricantes noche",
                        "children": []
                      },
                      {
                        "text": "├─ Primas diplopía",
                        "children": []
                      },
                      {
                        "text": "└─ Toxina botulínica retracción",
                        "children": []
                      }
                    ]
                  }
                ]
              },
              {
                "text": "TRATAMIENTO\\NTIROIDEO",
                "children": [
                  {
                    "text": "→ Objetivos",
                    "children": [
                      {
                        "text": "├─ Control rápido",
                        "children": []
                      },
                      {
                        "text": "├─ Eutiroidismo",
                        "children": []
                      },
                      {
                        "text": "└─ Evitar hipotiroidismo",
                        "children": []
                      }
                    ]
                  },
                  {
                    "text": "→ I131",
                    "children": [
                      {
                        "text": "├─ Riesgo: ↑/↓OG",
                        "children": []
                      },
                      {
                        "text": "├─ Profilaxis esteroides",
                        "children": []
                      },
                      {
                        "text": "├─ Alto riesgo: 0.3-0. 5mg/kg/d x 3m",
                        "children": []
                      },
                      {
                        "text": "└─ Bajo riesgo: 0. 2mg/kg/d x 6sem",
                        "children": [
                          {
                            "text": "└─ CI: OG activa",
                            "children": []
                          }
                        ]
                      }
                    ]
                  }
                ]
              },
              {
                "text": "TRATAMIENTO\\NOCULAR",
                "children": [
                  {
                    "text": "→ OG leve",
                    "children": [
                      {
                        "text": "└─ Observación/selenio",
                        "children": []
                      }
                    ]
                  },
                  {
                    "text": "→ OG\\Nmoderada-grave",
                    "children": [
                      {
                        "text": "├─ Metilprednisolona\\Niv",
                        "children": [
                          {
                            "text": "├─ 500mg/sem x 6sem",
                            "children": []
                          },
                          {
                            "text": "└─ 250mg/sem x 6sem",
                            "children": []
                          },
                          {
                            "text": "└─ Dosis acumulada: 7. 5g",
                            "children": []
                          }
                        ]
                      }
                    ]
                  },
                  {
                    "text": "→ CI MPIV",
                    "children": [
                      {
                        "text": "├─ Hepatitis viral reciente",
                        "children": []
                      },
                      {
                        "text": "├─ Disfunción hepática",
                        "children": []
                      },
                      {
                        "text": "└─ HTA/DM no controlada",
                        "children": []
                      }
                    ]
                  }
                ]
              }
            ]
          },
          {
            "text": "ALGORITMO\\NTRATAMIENTO OG",
            "children": [
              {
                "text": "MEDIDAS\\NGENERALES TODOS",
                "children": [
                  {
                    "text": "→ Restaurar eutiroidismo",
                    "children": []
                  },
                  {
                    "text": "→ Abandono tabaco inmediato",
                    "children": []
                  },
                  {
                    "text": "→ Medidas locales",
                    "children": []
                  },
                  {
                    "text": "→ Derivar especialista\\N{excepto leves}",
                    "children": []
                  }
                ]
              },
              {
                "text": "SEGÚN\\NSEVERIDAD",
                "children": [
                  {
                    "text": "→ Leve",
                    "children": [
                      {
                        "text": "├─ Observación + selenio",
                        "children": []
                      },
                      {
                        "text": "└─ GC iv si ↓QoL",
                        "children": []
                      }
                    ]
                  },
                  {
                    "text": "→ Moderada-grave",
                    "children": [
                      {
                        "text": "├─ Activa",
                        "children": [
                          {
                            "text": "└─ GC iv 1ª línea",
                            "children": []
                          }
                        ]
                      },
                      {
                        "text": "└─ Inactiva",
                        "children": [
                          {
                            "text": "└─ Rehabilitación Qx",
                            "children": []
                          }
                        ]
                      }
                    ]
                  },
                  {
                    "text": "→ NOD",
                    "children": [
                      {
                        "text": "├─ GC iv",
                        "children": [
                          {
                            "text": "├─ Si mala respuesta (2sem)",
                            "children": []
                          }
                        ]
                      },
                      {
                        "text": "└─ Descompresión urgente",
                        "children": [
                          {
                            "text": "└─ Nueva GC iv si persiste activa",
                            "children": []
                          }
                        ]
                      }
                    ]
                  }
                ]
              },
              {
                "text": "SEGUIMIENTO",
                "children": [
                  {
                    "text": "→ Respuesta GC iv",
                    "children": [
                      {
                        "text": "├─ Estable/inactiva → Rehabilitación",
                        "children": []
                      },
                      {
                        "text": "└─ Progresión → Alternativas",
                        "children": []
                      }
                    ]
                  },
                  {
                    "text": "→ Cirugía rehabilitadora",
                    "children": [
                      {
                        "text": "└─ Solo fase inactiva",
                        "children": []
                      }
                    ]
                  }
                ]
              }
            ]
          },
          {
            "text": "DERMOPATÍA GRAVES",
            "children": [
              {
                "text": "→ Características\\Ngenerales",
                "children": [
                  {
                    "text": "├─ Mixedema pretibial/local",
                    "children": []
                  },
                  {
                    "text": "├─ Infrecuente {<1%}",
                    "children": []
                  },
                  {
                    "text": "└─ Asociado OG + ↑TRAb",
                    "children": []
                  }
                ]
              },
              {
                "text": "→ Manifestaciones\\Ncutáneas",
                "children": [
                  {
                    "text": "├─ Edema sin fóvea rosáceo",
                    "children": []
                  },
                  {
                    "text": "├─ Folículos prominentes",
                    "children": []
                  },
                  {
                    "text": "├─ Textura piel naranja",
                    "children": []
                  },
                  {
                    "text": "└─ Placas/nódulos/elefantiasis",
                    "children": []
                  }
                ]
              },
              {
                "text": "→ Patogenia",
                "children": [
                  {
                    "text": "├─ Similar OG",
                    "children": []
                  },
                  {
                    "text": "├─ ↑Fibroblastos dérmicos",
                    "children": []
                  },
                  {
                    "text": "└─ ↑GAGs/presión local",
                    "children": []
                  }
                ]
              },
              {
                "text": "→ Tratamiento",
                "children": [
                  {
                    "text": "├─ Observación frecuente",
                    "children": [
                      {
                        "text": "└─ Si sintomático",
                        "children": []
                      }
                    ]
                  },
                  {
                    "text": "├─ Corticoides tópicos",
                    "children": []
                  },
                  {
                    "text": "└─ Vendajes compresión",
                    "children": []
                  }
                ]
              }
            ]
          }
        ]
      },
      {
        "text": "GRAVES Y\\NEMBARAZO ",
        "children": [
          {
            "text": "CARACTERÍSTICAS\\NGENERALES",
            "children": [
              {
                "text": "→ Epidemiología",
                "children": [
                  {
                    "text": "├─ Incidencia: 0.2%",
                    "children": []
                  },
                  {
                    "text": "├─ Causa más frecuente",
                    "children": []
                  },
                  {
                    "text": "└─ ↑Riesgo aborto/complicaciones",
                    "children": []
                  }
                ]
              },
              {
                "text": "→ Sistema inmune\\Nembarazo",
                "children": [
                  {
                    "text": "├─ Supresión respuestas AI",
                    "children": []
                  },
                  {
                    "text": "└─ Tolerancia materno-fetal",
                    "children": []
                  }
                ]
              }
            ]
          },
          {
            "text": "AUTOINMUNIDAD",
            "children": [
              {
                "text": "→ Anticuerpos",
                "children": [
                  {
                    "text": "├─ ↓TPOAb/TgAb/TRAb x placenta",
                    "children": []
                  },
                  {
                    "text": "├─ ↑Células T reguladoras",
                    "children": []
                  },
                  {
                    "text": "└─ ↑Inmunosupresión postparto",
                    "children": []
                  }
                ]
              },
              {
                "text": "→ Implicaciones",
                "children": [
                  {
                    "text": "├─ Tirotoxicosis fetal {1%}",
                    "children": []
                  },
                  {
                    "text": "└─ Correlación TRAb-daño fetal",
                    "children": []
                  }
                ]
              }
            ]
          },
          {
            "text": "DIAGNÓSTICO",
            "children": [
              {
                "text": "→ Alteraciones\\Nembarazo",
                "children": [
                  {
                    "text": "├─ ↑TBG x estrógenos",
                    "children": []
                  },
                  {
                    "text": "├─ ↑T4/T3 total {1.5x}",
                    "children": []
                  },
                  {
                    "text": "└─ ↓TSH fases iniciales",
                    "children": []
                  }
                ]
              },
              {
                "text": "→ Valores específicos",
                "children": [
                  {
                    "text": "├─ TSH: rangos propios",
                    "children": []
                  },
                  {
                    "text": "└─ T4L: métodos específicos",
                    "children": []
                  }
                ]
              },
              {
                "text": "→ Confirmación",
                "children": [
                  {
                    "text": "├─ TSH ↓",
                    "children": []
                  },
                  {
                    "text": "├─ T4L/T3L ↑",
                    "children": []
                  },
                  {
                    "text": "└─ TRAb +",
                    "children": []
                  }
                ]
              }
            ]
          },
          {
            "text": "COMPLICACIONES",
            "children": [
              {
                "text": "→ Obstétricas",
                "children": [
                  {
                    "text": "├─ ↑Aborto espontáneo/recurrente",
                    "children": []
                  },
                  {
                    "text": "├─ Parto pretérmino",
                    "children": []
                  },
                  {
                    "text": "├─ Preeclampsia",
                    "children": []
                  },
                  {
                    "text": "└─ RCIU",
                    "children": []
                  }
                ]
              },
              {
                "text": "├─ Bocio fetal",
                "children": []
              },
              {
                "text": "└─ Tirotoxicosis neonatal",
                "children": []
              },
              {
                "text": "→ Fetales/Neonatales",
                "children": [
                  {
                    "text": "├─ HiperT/HipoT por TRAb",
                    "children": []
                  }
                ]
              }
            ]
          },
          {
            "text": "ANTITIROIDEOS\\NEN EMBARAZO",
            "children": [
              {
                "text": "→ Características\\Nfarmacocinéticas",
                "children": [
                  {
                    "text": "├─ Atraviesan placenta",
                    "children": []
                  },
                  {
                    "text": "└─ PTU/MMZ: 20:1 potencia",
                    "children": []
                  }
                ]
              },
              {
                "text": "→ Efectos teratógenos",
                "children": [
                  {
                    "text": "├─ MMZ: 2-4% malformaciones",
                    "children": [
                      {
                        "text": "├─ Aplasia cutánea",
                        "children": []
                      },
                      {
                        "text": "├─ Atresia esofágica",
                        "children": []
                      },
                      {
                        "text": "└─ Defectos faciales",
                        "children": []
                      }
                    ]
                  },
                  {
                    "text": "└─ PTU: 1/40 malformaciones",
                    "children": []
                  }
                ]
              },
              {
                "text": "→ Recomendaciones",
                "children": [
                  {
                    "text": "├─ 1°trimestre: PTU",
                    "children": [
                      {
                        "text": "├─ Post-organogénesis: MMZ",
                        "children": []
                      }
                    ]
                  },
                  {
                    "text": "└─ Dosis mínima eficaz",
                    "children": []
                  }
                ]
              },
              {
                "text": "→ Seguimiento",
                "children": [
                  {
                    "text": "├─ Control función tiroidea",
                    "children": []
                  },
                  {
                    "text": "└─ Vigilar efectos adversos",
                    "children": []
                  }
                ]
              }
            ]
          },
          {
            "text": "CUIDADO PRENATAL",
            "children": [
              {
                "text": "→ Objetivo principal",
                "children": [
                  {
                    "text": "└─ Nacimiento niño sano",
                    "children": []
                  }
                ]
              },
              {
                "text": "→ Consideraciones",
                "children": [
                  {
                    "text": "├─ TRAb atraviesan placenta",
                    "children": []
                  },
                  {
                    "text": "├─ Antitiroideos cruzan placenta",
                    "children": []
                  },
                  {
                    "text": "└─ Control madre + feto",
                    "children": []
                  }
                ]
              },
              {
                "text": "→ Monitorización",
                "children": [
                  {
                    "text": "├─ FC fetal",
                    "children": []
                  },
                  {
                    "text": "├─ Crecimiento fetal",
                    "children": []
                  },
                  {
                    "text": "└─ ECO: bocio fetal",
                    "children": []
                  }
                ]
              }
            ]
          },
          {
            "text": "TRATAMIENTO\\NESPECÍFICO",
            "children": [
              {
                "text": "→ Antitiroideos",
                "children": [
                  {
                    "text": "├─ Dosis mínima eficaz",
                    "children": []
                  },
                  {
                    "text": "├─ T4L límite superior-normal",
                    "children": []
                  },
                  {
                    "text": "└─ No normalizar TSH",
                    "children": []
                  }
                ]
              },
              {
                "text": "→ Yodo/β-bloqueantes",
                "children": [
                  {
                    "text": "├─ I131: contraindicado",
                    "children": []
                  },
                  {
                    "text": "├─ β-bloqueantes: seguros corto plazo",
                    "children": []
                  },
                  {
                    "text": "└─ Propranolol: riesgo RCIU",
                    "children": []
                  }
                ]
              },
              {
                "text": "→ Cirugía",
                "children": [
                  {
                    "text": "├─ 2° trimestre si necesaria",
                    "children": []
                  },
                  {
                    "text": "├─ Preparación: yodo 7-10d",
                    "children": []
                  },
                  {
                    "text": "└─ Riesgo: TRAb persisten",
                    "children": []
                  }
                ]
              }
            ]
          },
          {
            "text": "SEGUIMIENTO",
            "children": [
              {
                "text": "→ Control TSH frecuente",
                "children": [
                  {
                    "text": "├─ Respuesta metabólica variable",
                    "children": []
                  },
                  {
                    "text": "└─ Ajuste dosis según clínica",
                    "children": []
                  }
                ]
              },
              {
                "text": "→ Final embarazo",
                "children": [
                  {
                    "text": "└─ TRAb >3x → riesgo tirotoxicosis fetal",
                    "children": []
                  }
                ]
              }
            ]
          }
        ]
      },
      {
        "text": "GRAVES\\NPOSTPARTO",
        "children": [
          {
            "text": "→ Cambios\\Ninmunes postparto",
            "children": [
              {
                "text": "├─ ↑Células Th1",
                "children": []
              },
              {
                "text": "├─ ↓Células reguladoras",
                "children": []
              },
              {
                "text": "└─ ↑Autoanticuerpos",
                "children": []
              }
            ]
          },
          {
            "text": "→ Tiroiditis postparto",
            "children": [
              {
                "text": "├─ Frecuente: 4-12m postparto",
                "children": []
              },
              {
                "text": "├─ Destrucción tiroidea",
                "children": []
              },
              {
                "text": "└─ Doble pico casos AI",
                "children": []
              }
            ]
          },
          {
            "text": "→ Presentación",
            "children": [
              {
                "text": "├─ Edad: 20-35a",
                "children": []
              },
              {
                "text": "├─ Antecedente embarazo 12m",
                "children": []
              },
              {
                "text": "└─ 78% recidivas postparto",
                "children": []
              }
            ]
          },
          {
            "text": "→ Tipos",
            "children": [
              {
                "text": "├─ HiperT + ↑captación RAI",
                "children": []
              },
              {
                "text": "├─ HiperT transitorio + RAI normal",
                "children": []
              },
              {
                "text": "└─ HiperT transitorio + ↓RAI",
                "children": []
              }
            ]
          }
        ]
      },
      {
        "text": "PREGESTACIONAL",
        "children": [
          {
            "text": "→ Consideraciones",
            "children": [
              {
                "text": "├─ Remisión antitiroideos",
                "children": []
              },
              {
                "text": "└─ Graves activa",
                "children": []
              }
            ]
          },
          {
            "text": "→ RAI previo",
            "children": [
              {
                "text": "├─ Esperar 6m-1a",
                "children": []
              },
              {
                "text": "└─ Control TRAb post-RAI",
                "children": []
              }
            ]
          }
        ]
      }
    ]
  },
  "related_maps": [
    {
      "id": "map_1689",
      "title": "SPRINTT (2021)\\NSarcopenia and Physical\\NFragility in Older People:\\NMulti-component Treatment\\N\\n⭐ Ejercicio + nutrición reduce\\ndiscapacidad en fragilidad física\\ncon sarcopenia"
    },
    {
      "id": "map_1633",
      "title": "ACV: ESCALAS DE UTILIDAD CLÍNICA"
    },
    {
      "id": "map_1673",
      "title": "DAPA-CKD (2020)\\NDapagliflozin And Prevention\\Nof Adverse outcomes in CKD\\N\\N⭐ iSGLT2 protege riñón\\NINCLUSO SIN DIABETES\\N(Extiende beneficio a ERC no-DM)"
    },
    {
      "id": "map_1674",
      "title": "CREDENCE (2019)\\NCanagliflozin and Renal Events in Diabetes\\N\\nCanagliflozina reduce progresion ERC\\ny eventos CV en DM2 con nefropatia\\nNNTH 22 para outcome renal"
    },
    {
      "id": "map_1780",
      "title": "Diagnóstico de Laboratorio\\Nde la Tuberculosis (TB)"
    }
  ],
  "source_file": "E.Graves[TRAb]-2024.smmx",
  "created": "2026-02-07T15:43:01.288560"
}